表紙
市場調查報告書

呼吸系統疾病治療藥的全球市場:未來預測 (到2022年)

Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

出版商 The Business Research Company 商品編碼 531335
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
呼吸系統疾病治療藥的全球市場:未來預測 (到2022年) Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
出版日期: 2020年05月19日內容資訊: 英文
簡介

本報告提供全球呼吸系統疾病治療藥的市場結構、趨勢相關分析,市場的主要特徵、結構,及整體市場規模、成長率趨勢預測,各類型、各地區、主要國家詳細趨勢,與主要宏觀經濟指標的對比,主要企業的簡介,近幾年的市場主要趨勢等調查。

第1章 摘要整理

第2章 分析結構

第3章 呼吸系統疾病治療藥市場特徵

第4章 呼吸系統疾病治療藥市場:各產品分析

  • 主要的產品/服務
  • 主要的功能與差異化要素
  • 開發中的產品

第5章 呼吸系統疾病治療藥市場供應鏈

  • 供應鏈
  • 流通
  • 最後客戶

第6章 呼吸系統疾病治療藥市場:客戶資訊

  • 客戶方面的偏好
  • 最終用途市場規模和成長率

第7章 呼吸系統疾病治療藥市場:趨勢與策略

第8章 呼吸系統疾病治療藥:市場規模與成長率

  • 市場規模
  • 市場成長率:成果值 (以金額為準)
    • 推動市場要素
    • 阻礙市場要素
  • 市場成長率:預測值 (以金額為準)
    • 推動市場要素
    • 阻礙市場要素

第9章 呼吸系統疾病治療藥的市場:各地區的分析

  • 市場規模的最新值:各地區 (以金額為準,2018年)
  • 市場規模的成果值、預測值:各地區 (以金額為準,2014∼2022年)
  • 成長率、市場佔有率比較:各地區

第10章 呼吸系統疾病治療藥的市場:各市場區隔分析

  • 各市場區隔的市場規模:成果值、預測值 (以金額為準,2014∼2022年)
    • 抗氣喘藥/COPD治療藥
    • 感冒藥

第11章 呼吸系統疾病治療藥的市場:主要指標

  • 市場規模佔GDP比率 (全球,2014∼2022年)
  • 平均每人平均支出額 (全球,2014∼2022年)

第12章 亞太地區的呼吸系統疾病治療藥的市場

  • 市場概要
  • 市場規模的最新值:各國 (以金額為準,2018年)
  • 市場規模的成果值、預測值:各國 (2014∼2022年)
  • 市場成長率、市場佔有率:各國比較 (2014∼2022年)
  • 相關指標
    • 每人支出額 (2014∼2022年)
    • 氣喘盛行率 (2018年)
  • 市場規模:各類型 (以金額為準,2014∼2022年)
  • 各國分析
    • 中國
    • 澳洲
    • 香港
    • 印度
    • 印尼
    • 日本
    • 馬來西亞
    • 紐西蘭
    • 菲律賓
    • 新加坡
    • 韓國
    • 泰國
    • 越南

第13章 西歐的呼吸系統疾病治療藥的市場

  • 各國分析
    • 奧地利
    • 比利時
    • 丹麥
    • 芬蘭
    • 法國
    • 德國
    • 愛爾蘭
    • 義大利
    • 荷蘭
    • 挪威
    • 葡萄牙
    • 西班牙
    • 瑞典
    • 瑞士
    • 英國

第14章 東歐的呼吸系統疾病治療藥的市場

  • 各國分析
    • 捷克
    • 波蘭
    • 羅馬尼亞
    • 俄羅斯

第15章 北美的呼吸系統疾病治療藥的市場

  • 各國分析
    • 加拿大
    • 墨西哥
    • 美國

第16章 南美的呼吸系統疾病治療藥的市場

  • 各國分析
    • 阿根廷
    • 巴西
    • 智利
    • 哥倫比亞
    • 秘魯
    • 委內瑞拉

第17章 中東的呼吸系統疾病治療藥的市場

  • 各國分析
    • 沙烏地阿拉伯
    • 以色列
    • 土耳其
    • 阿拉伯聯合大公國 (UAE)

第18章 非洲的呼吸系統疾病治療藥的市場

  • 各國分析
    • 埃及
    • 奈及利亞
    • 南非

第19章 呼吸系統疾病治療藥市場競爭情形

  • 競爭市場概要
  • 市場佔有率
  • 企業簡介
    • GlaxosmithKline Plc
    • AstraZeneca Plc
    • Merck & Co
    • Novartis AG
    • Johnson & Johnson

第20章 呼吸系統疾病治療藥市場上主要企業合併、收購 (M&A)

第21章 市場背景情況:醫藥品市場

  • 市場特徵
  • 市場規模、成長率的變化與預測:各領域 (以金額為準,2014∼2022年)
  • 市場規模:各地區 (以金額為準,2018年)
  • 市場規模:各地區 (2014∼2022年)
  • 市場規模:各類型 (以金額為準,2014∼2022年)

第22章 建議

  • 對成長國的建議
  • 對成長領域的建議
  • 成長策略的建議

第23章 附錄

第24章 著作權、免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

‘Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for respiratory diseases drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the respiratory diseases drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Respiratory Diseases Drugs Market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider respiratory diseases drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the respiratory diseases drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, respiratory diseases drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: GlaxosmithKline Plc; AstraZeneca Plc; Merck & Co; Novartis AG; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, respiratory diseases drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends And Strategies

8. Respiratory Diseases Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Respiratory Diseases Drugs Market Regional Analysis

  • 9.1. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

10. Respiratory Diseases Drugs Market Segmentation

  • 10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

  • 10.2. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Respiratory Diseases Drugs Market Metrics

  • 11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Respiratory Diseases Drugs Market

  • 12.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
  • 12.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics
    • 12.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
    • 12.7.1. China Respiratory Diseases Drugs Market
      • 12.7.1.1. China Respiratory Diseases Drugs Market Overview
      • 12.7.1.2. China Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Respiratory Diseases Drugs Market
      • 12.7.2.1. Australia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Respiratory Diseases Drugs Market
      • 12.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Respiratory Diseases Drugs Market
      • 12.7.4.1. India Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Respiratory Diseases Drugs Market
      • 12.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Respiratory Diseases Drugs Market
      • 12.7.6.1. Japan Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Respiratory Diseases Drugs Market
      • 12.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Respiratory Diseases Drugs Market
      • 12.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Respiratory Diseases Drugs Market
      • 12.7.9.1. Philippines Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Respiratory Diseases Drugs Market
      • 12.7.10.1. Singapore Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Respiratory Diseases Drugs Market
      • 12.7.11.1. South Korea Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Respiratory Diseases Drugs Market
      • 12.7.12.1. Thailand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Respiratory Diseases Drugs Market
      • 12.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

  • 13.1. Western Europe Respiratory Diseases Drugs Market Overview
  • 13.2. Western Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Respiratory Diseases Drugs Market Metrics
    • 13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis
    • 13.7.1. Austria Respiratory Diseases Drugs Market
      • 13.7.1.1. Austria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Respiratory Diseases Drugs Market
      • 13.7.2.1. Belgium Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Respiratory Diseases Drugs Market
      • 13.7.3.1. Denmark Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Respiratory Diseases Drugs Market
      • 13.7.4.1. Finland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Respiratory Diseases Drugs Market
      • 13.7.5.1. France Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Respiratory Diseases Drugs Market
      • 13.7.6.1. Germany Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Respiratory Diseases Drugs Market
      • 13.7.7.1. Ireland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Respiratory Diseases Drugs Market
      • 13.7.8.1. Italy Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Respiratory Diseases Drugs Market
      • 13.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Respiratory Diseases Drugs Market
      • 13.7.10.1. Norway Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Respiratory Diseases Drugs Market
      • 13.7.11.1. Portugal Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Respiratory Diseases Drugs Market
      • 13.7.12.1. Spain Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Respiratory Diseases Drugs Market
      • 13.7.13.1. Sweden Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Respiratory Diseases Drugs Market
      • 13.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Respiratory Diseases Drugs Market
      • 13.7.15.1. UK Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

  • 14.1. Eastern Europe Respiratory Diseases Drugs Market Overview
  • 14.2. Eastern Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics
    • 14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Respiratory Diseases Drugs Market,
      • 14.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Respiratory Diseases Drugs Market
      • 14.7.2.1. Poland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Respiratory Diseases Drugs Market
      • 14.7.3.1. Romania Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Respiratory Diseases Drugs Market
      • 14.7.4.1. Russia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

  • 15.1. North America Respiratory Diseases Drugs Market Overview
  • 15.2. North America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Respiratory Diseases Drugs Market Metrics
    • 15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, North America Countries
  • 15.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Respiratory Diseases Drugs Market: Country Analysis
    • 15.7.1. Canada Respiratory Diseases Drugs Market
      • 15.7.1.1. Canada Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Respiratory Diseases Drugs Market
      • 15.7.2.1. Mexico Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Respiratory Diseases Drugs Market
      • 15.7.3.1. USA Respiratory Diseases Drugs Market Overview
      • 15.7.3.2. USA Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

  • 16.1. South America Respiratory Diseases Drugs Market Overview
  • 16.2. South America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Respiratory Diseases Drugs Market Metrics
    • 16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, South America Countries
  • 16.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Respiratory Diseases Drugs Market: Country Analysis
    • 16.7.1. Argentina Respiratory Diseases Drugs Market
      • 16.7.1.1. Argentina Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Respiratory Diseases Drugs Market
      • 16.7.1.1. Brazil Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Respiratory Diseases Drugs Market
      • 16.7.3.1. Chile Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Respiratory Diseases Drugs Market
      • 16.7.4.1. Colombia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Respiratory Diseases Drugs Market
      • 16.7.5.1. Peru Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Respiratory Diseases Drugs Market
      • 16.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

  • 17.1. Middle East Respiratory Diseases Drugs Market Overview
  • 17.2. Middle East, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Respiratory Diseases Drugs Market Metrics
    • 17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Respiratory Diseases Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Respiratory Diseases Drugs Market
      • 17.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Respiratory Diseases Drugs Market
      • 17.7.2.1. Israel Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Respiratory Diseases Drugs Market
      • 17.7.3.1. Turkey Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Respiratory Diseases Drugs Market
      • 17.7.4.1. UAE Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

  • 18.1. Africa Respiratory Diseases Drugs Market Overview
  • 18.2. Africa, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Respiratory Diseases Drugs Market Metrics
    • 18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Respiratory Diseases Drugs Market: Country Analysis
    • 18.7.1. Egypt Respiratory Diseases Drugs Market
      • 18.7.1.1. Egypt Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Respiratory Diseases Drugs Market
      • 18.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Respiratory Diseases Drugs Market
      • 18.7.3.1. South Africa Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. GlaxosmithKline Plc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. AstraZeneca Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Merck & Co
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Novartis AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Johnson & Johnson
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Respiratory Diseases Drugs Market In 2023- Growth Countries
  • 22.2. Global Respiratory Diseases Drugs Market In 2023- Growth Segments
  • 22.3. Global Respiratory Diseases Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer